Career Updates

Aug 30, 2025, 15:13

Dr. Aman Chauhan Elected to NANETS Board of Directors – Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center shared a post on LinkedIn:

“The North American Neuroendocrine Tumor Society (NANETS) has announced the election of Aman Chauhan, M.D., to its Board of Directors for a two-year term. Dr. Chauhan, a nationally recognized leader in neuroendocrine tumor research and treatment, will begin his term following the NANETS Annual Meeting, scheduled for Oct. 23–25, in Austin, Texas.

“It is an honor to be elected to the NANETS Board of Directors,” said Dr. Chauhan, who currently serves as the Leader of the Neuroendocrine Tumor Program and Co-Director of the Theranostic Program at Sylvester Comprehensive Cancer Center, part of University of Miami Miller School of Medicine.

His appointment to the NANETS Board reflects his significant contributions to the field, including pioneering work in theranostics and radiopharmaceuticals, as well as his leadership in advancing clinical trials for neuroendocrine cancers.

A graduate of Kasturba Medical College in India, Dr. Chauhan completed dual residency training in internal medicine and pediatrics at Louisiana State University, followed by a hematology and oncology fellowship at the University of Kentucky. His specialized training in neuroendocrine tumors under the guidance of Lowell Anthony, M.D., and an externship at the National Cancer Institute laid the foundation for his innovative approach to NET care.

“My dream is to help advance the field, develop new treatments, and to see improvement of patients’ overall outcomes,” he said, when he joined Sylvester.

Dr. Chauhan has authored more than 100 scientific publications and book chapters and has received multiple career development awards from the National Cancer Institute. His work has been recognized by leading organizations, including NANETS and the Neuroendocrine Cancer Awareness Network (NCAN).

In addition to his clinical and research leadership, Dr. Chauhan chairs the Communications Committee for NANETS and co-leads the Neuroendocrine Tumor Committee at the Southwest Oncology Group (SWOG). He also played a pivotal role in updating the American Joint Committee on Cancer (AJCC) staging guidelines for neuroendocrine tumors, leading the chapter on appendiceal NETs and co-authoring a widely cited summary paper to make the guidelines more accessible to clinicians. He is also a member of ASCO NET guidelines as well as NCI’s NET Task Force.

At Sylvester, Dr. Chauhan has built a site-agnostic, multidisciplinary Neuroendocrine Oncology program that integrates medical oncology, surgery, nuclear medicine and interventional radiology. He also leads early-phase clinical trials, including first-in-human studies, and serves as the national principal investigator for several theranostic trials.

His commitment to patient-centered care and translational research continues to shape the future of neuroendocrine tumor treatment both regionally and nationally.”

More posts featuring Aman Chauhan.